Article Text

Download PDFPDF

The bacterial effector protein YopM is a selfdelivering immune therapeutic agent that reduces inflammation in rheumatoid arthritis
  1. J Bertrand,
  2. C Rüther,
  3. J Scharnert,
  4. M Niedermeier,
  5. A Schmidt,
  6. T Pap
  1. Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Germany

Statistics from Altmetric.com

Synovial fibroblasts (RASF) are active drivers of joint destruction in rheumatoid arthritis (RA) through the production of cytokines that maintain the inflammatory process. The Yersinia outer protein M (YopM) is an effector protein of pathogenic Yersinia and is able to enter host cells by membrane penetration and subsequent downregulation of inflammatory responses. Here, we investigated whether YopM has the potential to act as a ‘self-delivering’ immune therapeutic agent by exhibiting a beneficial effect on inflammation and joint destruction …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.